Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older …

…, N Wang, B Zhou, M Lewis, P Price-Abbott… - The Lancet Infectious …, 2022 - thelancet.com
Background Improved seasonal influenza vaccines for older adults that can induce broadly
cross-reactive antibodies and enhanced T-cell responses, particularly against A H3N2 …

[BOOK][B] Keith Richards: the biography

V Bockris - 2003 - books.google.com
In 1992, Victor Bockris's celebrated biography was the first to recognize Richards's pivotal
role in the Stones' legend. Now that book on rock's most incredible survivor has been …

[HTML][HTML] Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised …

MS Datoo, HM Natama, A Somé, D Bellamy… - The Lancet Infectious …, 2022 - thelancet.com
Background Malaria is a leading cause of morbidity and mortality worldwide. We previously
reported the efficacy of the R21/Matrix-M malaria vaccine, which reached the WHO-specified …

[HTML][HTML] Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled …

MS Datoo, MH Natama, A Somé, O Traoré, T Rouamba… - The Lancet, 2021 - thelancet.com
Background Stalled progress in controlling Plasmodium falciparum malaria highlights the
need for an effective and deployable vaccine. RTS,S/AS01, the most effective malaria vaccine …

COVID-19 Vaccine Placebo Group Analyses

S Günther, D Lucey, B Renaud - JAMA Network Open, 2023 - jamanetwork.com
The COVID-19 pandemic, caused by SARS-CoV-2, has had many society-wide health,
economic, educational, and political impacts. According to the World Health Organization, as of …